CK-869 is an Actin-Related Protein 2/3 (ARP2/3) complex inhibitor, with an IC50 of 7 μM.
Product Application
CK-869 has been used as an Arp2/3 complex inhibitor:
to treat cultured mammalian cells and study its in vitro and in vivo effects on microtubule assembly
to induce membrane blebbing in HT1080 fibrosarcoma cells
to treat KDM3A-null cells and study the relation between actin dynamics and ciliogenesis
规格
别名
2-(3-溴苯基)-3-(2,4-二甲氧基苯基)-4-噻唑烷酮
英文别名
HMS623C22 | CCG-33400 | 2-(3-Bromophenyl)-3-(2,4-dimethoxyphenyl)-4-thiazolidinone | D80737 | BS-17180 | EX-A2784 | SR-01000553731-1 | CK 869 | CK 869; CK869; CK-0157869; CK 0157869; CK0157869 | 2-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)-1,3-thiazolidin-4-
规格或纯度
≥98%
英文名称
CK869
生化机理
人和牛肌动蛋白相关蛋白2/3(Arp2 / 3)复合物的抑制剂。用牛Arp2 / 3复合物抑制肌动蛋白聚合(IC 50 = 11μM),并抑制单核细胞增生李斯特菌引起的肌动蛋白丝彗星尾在感染的SKOV3细胞中的形成(IC50 = 7μM)。CK-0157869 (CK-869) prevents microtubule (MT) assembly, free of Arp2/3 complex.
CK-869 is a cell-permeable inhibitor of actin assembly mediated by the actin-related protein Arp2/3 complex of human and bovine, but not yeast. The actin-related protein Arp2/3 complex plays a major role in the regulation of the actin cytoskeleton. Apparently the compound binds to the hydrophobic core of Arp3 and alters its conformation.